CARTABegin with a defined use context.
The CARTA domains distinguish interests such as sustained attention, recall and evening rest. Universal Booster has a separate, complementary role.
ABOUT CARTA
More than another name on the shelf.
Choosing a wellness product can mean sorting through names, ingredient lists and formats without a clear reason to choose one. CARTA and PhytoLogic begin development with the role a product is meant to have in everyday life.
WHY CARTA EXISTS
A formulation should come with a clear explanation.
Explain the whole formulation.
The development direction connects ingredient identity, declared amounts and format to that role. Finished-product explanations should make those decisions understandable.
Keep information with the product.
Product identity, available batch details and source references belong together. Optional Continuum tools can retain that reference beside a person’s own observations.
TWO FAMILIES
Distinct approaches. A shared philosophy.
CARTA
Non-THC, hemp-derived cannabinoid wellness products organized around eight Outcome Domains, with Universal Booster as a separate option for situational support.
Explore CARTA →PhytoLogic
Six non-cannabinoid concepts spanning daily foundations and targeted support within a routine.
Explore PhytoLogic →Both product families are owned by Continuum and remain in development.
RELATIONSHIPS
Clear relationships behind the brands.
SignalArc, Cultivar Signals and Digestion Signals are standalone Continuum applications. CARTA does not own the apps, and users do not need CARTA products to use them.
CARTA PhytoTherapeutics is a separate regulated adult-use operator for THC-containing products and is not owned by Continuum Holdings. Its products are distinct from the CARTA non-THC hemp wellness family described here.
Meet ContinuumTHE THINKING BEHIND THE WORK
Start with the question behind the product.
Continuum’s founder describes why keeping a useful record matters, and why cannabinoids made the question especially visible.